The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

被引：0
|
作者：
Liu, Yang [1 ]
Zhao, Shuangtao [2 ]
Jiang, Changying [1 ]
Yao, Yixin [1 ]
Murfin, Kelley Paige [1 ]
Grundman, Hadley [1 ]
Zhang, Liang [1 ]
Nomie, Krystle [1 ]
Wang, Linghua [2 ]
Wang, Michael [1 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1487
引用
收藏
页数：3
相关论文
共 50 条
  • [31] CDK9 Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma (MCL)
    Roleder, Carly
    Dominguez, Edward C.
    Chen, Andrew
    Ball, Brian J.
    Danilova, Olga
    Danilov, Alexey
    BLOOD, 2023, 142
  • [32] Targeting PRMT5 to Circumvent Acquired Ibrutinib Resistance in Mantle Cell Lymphoma
    Sloan, Shelby
    Brown, Fiona
    Chung, Ji Hyun
    Prouty, Alexander
    Wheeler, Esther
    Harrington, Bonnie K.
    Brooks, Eric
    Yilmaz, Ayse S.
    Ozer, Hatice G.
    Byrd, John C.
    Chen-Kiang, Selina
    Di Liberto, Maurizio
    Lapalombella, Rosa
    Vaddi, Kris
    Scherle, Peggy
    Youssef, Youssef
    Baiocchi, Robert A.
    Alinari, Lapo
    BLOOD, 2019, 134
  • [33] DNMT3A-Mediated Oxidative Phosphorylation and Ibrutinib Resistance in Mantle Cell Lymphoma
    Nguyet Minh Hoang
    Liu, Yunxia
    Rui, Lixin
    BLOOD, 2022, 140 : 8762 - 8763
  • [34] Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
    Sun, Kai
    Kasparian, Saro
    Iyer, Swaminathan
    Pingali, Sai Ravi
    ECANCERMEDICALSCIENCE, 2018, 12
  • [35] Single-cell RNA-seq reveals heterogeneity, clonal evolution and strategies to overcome ibrutinib-venetoclax dual resistance in mantle cell lymphoma
    Jiang, Changying
    Zhang, Shaojun
    Wang, Yuanxin
    Zhang, Rongjia
    Liu, Yang
    McIntosh, Joseph
    Han, Guangchun
    Wang, Ruiping
    Santos, David
    Badillo, Maria
    Leeming, Angela
    Chen, Zhihong
    Hartig, Kimberly
    Bigcal, John
    Lee, Hun
    Steiner, Raphael
    Romaguera, Jorge
    Jain, Preetesh
    Nomie, Krystle
    Futreal, Andy
    Wang, Linghua
    Wang, Michael
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Can we improve on ibrutinib in mantle cell lymphoma?
    Rule, Simon
    LANCET HAEMATOLOGY, 2018, 5 (03): : E98 - E99
  • [37] Ibrutinib-associated Serositis in Mantle Cell Lymphoma
    Styskel, Brett A.
    Lopez-Mattei, Juan
    Jimenez, Carlos A.
    Stewart, John
    Hagemeister, Fredrick B.
    Faiz, Saadia A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : E43 - E44
  • [38] Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo
    Kopp, Nadja
    Tschuri, Sebastian
    Haebe, Sarah
    van Bodegom, Diederik
    Bird, Liat
    Christie, Amanda L.
    Saur, Amy
    Christodoulou, Alexandra N.
    Tivey, Trevor
    Kung, Andrew L.
    Weigert, Oliver
    Weinstock, David
    BLOOD, 2014, 124 (21)
  • [39] Abemaciclib-Based Combinational Therapies to Overcome Therapeutic Resistance in Mantle Cell Lymphoma
    Che, Yuxuan
    Liu, Yang
    Li, Lingzhi
    Hill, Holly
    McIntosh, Joseph
    Jordan, Alexa A.
    Jung, Dayoung
    Yao, Yixin
    Jiang, Vivian Changying
    Wang, Michael
    BLOOD, 2020, 136
  • [40] CDK9 As a New Therapeutic Vulnerability for Ibrutinib Resistance Mantle Cell Lymphoma (MCL)
    Wang, Michelle
    Zhao, Xiaohong
    Jiang, Huijuan
    Yan, Joy Catherine
    Sotomayor, Eduardo
    Shain, Kenneth H.
    Shah, Bijal
    Tao, Jianguo
    BLOOD, 2020, 136
12345